# RISPERIDONE
> **ANDA091537** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA USA · Approved 2011-03-30
## Drug
- **FDA Application Number:** ANDA091537
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RISPERIDONE
- **Generic name:** RISPERIDONE
- **Active ingredients:** RISPERIDONE
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NATCO PHARMA USA
- **Manufacturer:** Natco Pharma USA LLC
- **First approval:** 2011-03-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091537)
---
*AI Analytics · CC0 1.0*